Intervention-Related Changes in Coping Ability Drives Improvements in Mood and Quality of Life for Patients Taking Adjuvant Endocrine Therapy

被引:0
|
作者
Walsh, Leah E. [1 ]
Dunderdale, Laura [2 ]
Horick, Nora [2 ,3 ]
Temel, Jennifer S. [2 ,3 ]
Greer, Joseph A. [2 ,3 ]
Jacobs, Jamie M. [2 ,3 ]
机构
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] Massachusetts Gen Hosp, Boston, MA USA
[3] Harvard Med Sch, Boston, MA USA
基金
美国国家卫生研究院;
关键词
adjuvant endocrine therapy; breast cancer; cancer; coping skills; mediation; mood; oncology; quality of life; self-efficacy; COGNITIVE-BEHAVIORAL THERAPY; BREAST-CANCER; SYMPTOMS; DEPRESSION; MANAGEMENT; ADHERENCE; WOMEN; SURVIVORS; DISTRESS; ANXIETY;
D O I
10.1002/pon.70049
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveA recent randomized trial of a group psychosocial telehealth intervention (STRIDE) improved anxiety, depression, quality of life (QOL), symptom distress, coping, and self-efficacy to manage symptoms related to taking adjuvant endocrine therapy (AET) in women with non-metastatic hormone receptor-positive breast cancer. This study examined whether changes in coping and self-efficacy mediated intervention effects on anxiety, depression, QOL, and symptom distress.MethodWomen (N = 100) were recruited between 10/2019-06/2021 from Massachusetts General Hospital and were randomized to STRIDE or to the medication monitoring control group. Participants completed self-report measures of anxiety and depression (Hospital Anxiety and Depression Scale), QOL (Functional Assessment of Cancer Therapy-Breast Cancer scale), symptom distress (Breast Cancer Prevention Trial Symptom Scale), coping (Measure of Current Status-Part A), and self-efficacy (Self Efficacy for Managing AET Symptoms) at baseline and 24-week follow-up. Mediated regression models tested whether changes in coping ability and self-efficacy mediated the intervention effects on anxiety, depression, QOL, and symptom distress, controlling for key variables.ResultsImprovements in coping across the 24-week study period mediated the effect of STRIDE on anxiety symptoms (indirect effect, B = -0.61, SE = 0.28, 95% CI: -1.28, -0.17), depressive symptoms (indirect effect, B = -0.50, SE = 0.21, 95% CI: -0.97, -0.15), and QOL (indirect effect, B = 3.80, SE = 1.25, 95% CI: 1.54, 6.49), but not symptom distress. Changes in self-efficacy did not mediate improvements in any of the proposed outcomes.ConclusionCoping is an essential component of a brief group psychosocial intervention that drives improvements in mood and QOL for women with non-metastatic hormone receptor-positive breast cancer taking AET.Clinical trial registrationNCT03837496.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Therapy understanding and health related quality of life in stage III/IV melanoma patients treated with novel adjuvant therapies
    Reschke, Robin
    Jager, Iris
    Mehnert-Theuerkauf, Anja
    Ziemer, Mirjana
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 (02): : 215 - 221
  • [42] Health-related quality of life analysis in stage III melanoma patients treated with adjuvant dendritic cell therapy
    Bloemendal, M.
    Rietveld, M. J. A.
    van Willigen, W. W.
    Gerritsen, W. R.
    Figdor, C. G.
    Bonenkamp, J. J.
    Westdorp, H.
    Boudewijns, S.
    Koornstra, R. H. T.
    Adang, E. M. M.
    Schreibelt, G.
    Ottevanger, P. B.
    de Vries, I. J. M.
    Bol, K. F.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (06): : 774 - 780
  • [43] Changes in drug use are associated with health-related quality of life improvements among methadone maintenance patients with HIV/AIDS
    Bach Xuan Tran
    Arto Ohinmaa
    Anh Thuy Duong
    Nhan Thi Do
    Long Thanh Nguyen
    Quoc Cuong Nguyen
    Steve Mills
    Philip Jacobs
    Stan Houston
    Quality of Life Research, 2012, 21 : 613 - 623
  • [44] Changes in drug use are associated with health-related quality of life improvements among methadone maintenance patients with HIV/AIDS
    Bach Xuan Tran
    Ohinmaa, Arto
    Anh Thuy Duong
    Nhan Thi Do
    Long Thanh Nguyen
    Quoc Cuong Nguyen
    Mills, Steve
    Jacobs, Philip
    Houston, Stan
    QUALITY OF LIFE RESEARCH, 2012, 21 (04) : 613 - 623
  • [45] Changes in health-related quality of life in Head and Neck Patients Who Received Proton Therapy
    Chen, Y. H.
    Uyl-de Groot, C.
    van Vulpen, M.
    Blommestein, H.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S445 - S446
  • [46] Changes in quality of life and its related factors in liver cancer patients receiving stereotactic radiation therapy
    Shun, Shiow-Ching
    Chiou, Jeng-Fong
    Lai, Yeur-Hur
    Yu, Po-Jui
    Wei, Lin-Lin
    Tsai, Jo-Ting
    Kao, Chung-Yu
    Hsiao, Ya-Li
    SUPPORTIVE CARE IN CANCER, 2008, 16 (09) : 1059 - 1065
  • [47] Changes in quality of life and its related factors in liver cancer patients receiving stereotactic radiation therapy
    Shiow-Ching Shun
    Jeng-Fong Chiou
    Yeur-Hur Lai
    Po-Jui Yu
    Lin-Lin Wei
    Jo-Ting Tsai
    Chung-Yu Kao
    Ya-Li Hsiao
    Supportive Care in Cancer, 2008, 16 : 1059 - 1065
  • [48] Health-Related Quality of Life and Coping Strategies in a Cohort Study of Highly Active Antiretroviral Therapy Naive Patients Adherence
    Franca, Patricia de Oliveira
    Ayres, Lorena Rocha
    Pimassoni, Lucia Helena
    Cerutti Junior, Crispim
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2022, 2022 : 8341638
  • [49] Effects of a Clinical Exercise Program on Health-Related Fitness and Quality of Life in Spanish Cancer Patients Receiving Adjuvant Therapy
    GilHerrero, Lucia
    Courneya, Kerry S.
    McNeely, Margaret L.
    Castellanos, Monica
    Marquez, Ana Isabel Gonzalez
    Pollan, Marina
    Casla-Barrio, Soraya
    INTEGRATIVE CANCER THERAPIES, 2022, 21
  • [50] Role of individualized intervention(s) on quality of life (QoL) and adherence to adjuvant endocrine therapy in premenopausal women with early-stage breast cancer (bc): MyChoice study
    Ahmed, S.
    Chalchal, H. I.
    Dwernychuk, L.
    Iqbal, N.
    Salim, M.
    Gowan-Moody, D.
    Asif, T.
    Khan, M.
    Lim, J.
    Bulych, D.
    Ahmed, O.
    Sami, A.
    Kontulainen, S.
    Leis, A.
    ANNALS OF ONCOLOGY, 2019, 30 : 98 - 98